Vnitr Lek 2017, 63(11):750-756 | DOI: 10.36290/vnl.2017.146

A targeted search for patients with chronic obstructive pulmonary disease: brief summary

Vladimír Koblížek1,*, Karel Hejduk2,3
1 Plicní klinika LF UK a FN Hradec Králové
2 Institut biostatistiky a analýz, s.r.o., Brno
3 Ústav zdravotnických informací a statistiky ČR, Praha

Chronic obstructive pulmonary disease (COPD) is a leading cause mortality and morbidity globally, with permanently growing prevalence. Expressive underdiagnosis and undertreatment is a general features across all European countries. Individuals with undiagnosed, symptomatic COPD had significantly increased risk of exacerbations, pneumonia, and death. Early smoking cessation is able to reduce the mortality and morbidity burden of newly diagnosed COPD individuals. These findings suggest that better initiatives for early diagnosis and early treatment of COPD are needed. A clear diagnosis of COPD requires post-bronchodilator spirometry in symptomatic mid-elderly (more than 40) aged subjects with long-lasting inhalation exposure to known risk factors.

Keywords: COPD; morbidity; mortality; screening; spirometry; underdiagnosis

Received: September 4, 2017; Accepted: September 26, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koblížek V, Hejduk K. A targeted search for patients with chronic obstructive pulmonary disease: brief summary. Vnitr Lek. 2017;63(11):750-756. doi: 10.36290/vnl.2017.146.
Download citation

References

  1. Vogelmeier CF, Criner GJ, Martinez FJ et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 2017; 49(6): 1700214. Dostupné z DOI: <http://dx.doi.org/10.1183/13993003.50214-2017>. Erratum for Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. [Eur Respir J. 2017]. Go to original source... Go to PubMed...
  2. Koblížek V. Habilitační práce: Vliv fyzické zátěže na agregaci trombocytů u chronické obstrukční plicní nemoci. Univerzita Karlova-Lékařská fakulta: Hradec Králové 2017. Dostupné z WWW: Dostupné z WWW: <https://dspace.cuni.cz/handle/20.500.11956/91712>.
  3. Pocket guide to copd diagnosis, management, and prevention. A Guide for Health Care Professionals. 2017 REPORT. Dostupné z WWW: <http://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf>.
  4. Bestall JC, Paula EA, Garroda R et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(7): 581-586. Go to original source... Go to PubMed...
  5. Kokturk N, Kilic H, Baha A et al. Sex Difference in Chronic Obstructive Lung Disease. Does it Matter? A Concise Review. COPD 2016; 13(6): 799-806. Go to original source... Go to PubMed...
  6. Martinez CH, Diaz AA, Parulekar AD et al. Age-related differences in health-related quality of life in COPD: an analysis of the COPDGene and SPIROMICS cohorts. Chest 2016; 149(4): 927-935. Dostupné z DOI: <http://dx.doi.org/10.1016/j.chest.2015.11.025>. Go to original source... Go to PubMed...
  7. Celli B, Blasi F, Gaga M et al. Perception of symptoms and quality of life - comparison of patients' and physicians' views in the COPD MIRROR study. Int J Chron Obstruct Pulmon Dis 2017; 12: 2189-2196. Dostupné z DOI: <http://dx.doi.org/10.2147/COPD.S136711>. Go to original source... Go to PubMed...
  8. McGarvey L, Morice AH, Smith JA et al. Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respir Res 2016; 3(1): e000148. Dostupné z DOI: <http://dx.doi.org/10.1136/bmjresp-2016-000148>. Go to original source... Go to PubMed...
  9. Nakken N, Janssen DJ, van den Bogaart EH et al. Patient versus proxy-reported problematic activities of daily life in patients with COPD. Respirology 2017; 22(2): 307-314. Dostupné z DOI: <http://dx.doi.org/10.1111/resp.12915>. Go to original source... Go to PubMed...
  10. Cannon DT, Coelho AC, Cao R et al. Skeletal muscle power and fatigue at the tolerable limit of ramp-incremental exercise in COPD. J Appl Physiol 2016; 121(6): 1365-1373. Dostupné z DOI: <http://dx.doi.org/10.1152/japplphysiol.00660.2016>. Go to original source... Go to PubMed...
  11. Hurst JR. Exacerbation phenotyping in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184(6): 625-626.. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201106-1136ED>. Go to original source... Go to PubMed...
  12. Koblizek V, Milenkovic, B, Barczyk A et al. Phenotypes of COPD patients with a smoking history in Central and Eastern. Eur Respir J 2017; 49(5). pii: 1601446. Dostupné z DOI: <http://dx.doi.org/10.1183/13993003.01446-2016.>. Go to original source...
  13. Müllerova H, Maselli DJ, Locantore N et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest 2015; 147(4): 999-1007. Dostupné z DOI: <http://dx.doi.org/10.1378/chest.14-0655>. Go to original source... Go to PubMed...
  14. da Silva SM, Paschoal IA, De Capitani EM et. al. COPD phenotypes on computed tomography and its correlation with selected lung function variables in severe patients. Int J Chron Obstruct Pulmon Dis 2016; 11: 503-513. Dostupné z DOI: <http://dx.doi.org/10.2147/COPD.S90638>. Go to original source... Go to PubMed...
  15. Hurst JR, Elborn JS, De Soyza A et al. COPD-bronchiectasis overlap syndrome. Eur Respir J 2015; 45(2): 310-313. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00170014>. Go to original source... Go to PubMed...
  16. Vellas B, Fielding R, Bhasin S et al. Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging 2016; 5(4): 194-200. Go to original source...
  17. Stewart Coats AJ, Shewan LG. A comparison of research into cachexia, wasting and related skeletal muscle syndromes in three chronic disease areas. Int J Cardiol 2017; 235: 33-36. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijcard.2017.02.136>. Go to original source... Go to PubMed...
  18. Jones PW, Harding G, Berry P et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34(3): 648-654. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00102509>. Go to original source... Go to PubMed...
  19. Macklem PT. The terapeutic implications of the pathophysiology of COPD. Eur Respir J 2010; 35(3): 676-680. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00120609>. Go to original source... Go to PubMed...
  20. Boutou AK, Shrilkrishna D, Tanner RJ et al. Lung function indices for predicting mortality in COPD. Eur Respir J 2013; 42(3): 616-625. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00146012>. Go to original source... Go to PubMed...
  21. Lange P, Celli B, Agusti A et al. Lung function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015; 373(2): 111-122. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1411532>. Go to original source... Go to PubMed...
  22. Rossi A, Butorac-Petanjek B, Chilosi M et al. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societes. Int J Chron Obstruct Pulmon Dis 2017; 12: 2593-2610. Dostupné z DOI: <http://dx.doi.org/10.2147/COPD.S132236>. Go to original source... Go to PubMed...
  23. Frantz S, Nihlén U, Dencker M et al. Impulse oscilometry may be of value in detecting early manifestations of COPD. Respir Med 2012; 106(8): 1116-1123. Dostupné z DOI: <http://dx.doi.org/10.1016/j.rmed.2012.04.010>. Go to original source... Go to PubMed...
  24. Ofir D, Laveneziana O, Webb KA et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(6): 622-629. Go to original source... Go to PubMed...
  25. Elbehairy AF, Ciavaglia CE, Webb KA et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease: implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med 2015; 191(12): 1384-1394. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201501-0157OC>. Go to original source... Go to PubMed...
  26. Crook S, Büsching G, Schultz K et al. A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J 2017; 49(3). pii: 1601871. Dostupné z DOI: <http://dx.doi.org/10.1183/13993003.01871-2016>. Go to original source...
  27. Llordés M, Jaén A, Almagro P et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD 2015; 12(4): 404-412. Dostupné z DOI: <http://dx.doi.org/10.3109/15412555.2014.974736>. Go to original source... Go to PubMed...
  28. Lamprecht B, Soriano J, Studnicka M et al. [BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group; BOLD Collaborative Research Group the EPI-SCAN Team the PLATINO Team and the PREPOCOL Study Group]. Determinants of Underdiagnosis of COPD in national and international surveys. Chest 2015; 148: 971-985. Dostupné z DOI: <http://dx.doi.org/10.1378/chest.14-2535>. Go to original source... Go to PubMed...
  29. Castillo D, Burgos F, Guayta R et al. FARMAEPOC group. Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. Respir Med 2015; 109: 475-482. Dostupné z DOI: <http://dx.doi.org/10.1016/j.rmed.2015.02.009>. Go to original source... Go to PubMed...
  30. Zhang J, Zhou JB, Lin XF et al. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology 2013; 18(2): 297-302. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1440-1843.2012.02282.x>. Go to original source... Go to PubMed...
  31. Xu W, Collet J, Shapiro S et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J 2010; 35(5): 1022-1030. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00079409>. Go to original source... Go to PubMed...
  32. Langsetmo L, Platt RW, Ernst P et al. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008; 177(4): 396-401. Go to original source... Go to PubMed...
  33. Koblizek V, Novotna B, Zbozinkova Z et al. Diagnosing COPD: advances in training and practice - a systematic review. Adv Med Educ Pract 2016; 7: 219-231. Dostupné z DOI: <http://dx.doi.org/10.2147/AMEP.S76976>. Go to original source... Go to PubMed...
  34. Pallari E, Lewison G, Sullivan R. How is chronic non-communicable respiratory conditions research reported in European newspapers? An impact assessment for policy. Clin Respir J 2017; 11(5): 657-665. Dostupné z DOI: <http://dx.doi.org/10.1111/crj.12685>. Go to original source... Go to PubMed...
  35. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. Dostupné z WWW: <https://www.nice.org.uk/guidance/CG101/chapter/1-Guidance#diagnosing-copd>.
  36. Josephs L, Culliford D, Johnson M et al. Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study. Eur Respir J 2007; 49(5). pii: 1602114. Dostupné z DOI: <http://dx.doi.org/10.1183/13993003.02114-2016>. Go to original source...
  37. Colak Y, Afzal S, Nordestgaard BG et al. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med 2017; 5(5): 426-434. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213-2600(17)30119-4>. Go to original source... Go to PubMed...
  38. Capozzolo A, Castellana G, Dragonieri S et al. Voluntary lung function srceening to reveal new COPD cases in southern Italy. Int J Chron Obstruct Pulmon Dis 2017; 12: 2035-2042. Dostupné z DOI: <http://dx.doi.org/10.2147/COPD.S136357>. Go to original source... Go to PubMed...
  39. Jordan RE, Adab P, Sitch A et al. Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial. Lancet Respir Med 2016; 4(9): 720-730. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213-2600(16)30149-7>. Go to original source... Go to PubMed...
  40. Health Screening Services. What To Expect. Screening Packages. Health Screening Videos. What Experts Say About Cardiovascular Disease. Dostupné z WWW: <http://www.lifelinescreening.com/What-We-Do/What-We-Screen-For/COPD>.
  41. Guillien A, Soumagne TE, Puyraveau M et al. Case-Finding for Persistent Airway Obstruction in Farmers: A Questionnaire With Optimal Diagnosis Criteria. Am J Prev Med 2017. pii: S0749-3797(17)30361-6. In press. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amepre.2017.06.031>. Go to original source... Go to PubMed...
  42. Koblizek V, Svoboda M. Current position of new fixed-dose combination of tiotropium and olodaterol - its role in the treatment of chronic obstructive pulmonary disease in the Czech Republic. Vnitř Lék 2016; 62(12): 1011-1020. Article in Czech. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.